Marcum Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.79M Buy
3,375
+22
+0.7% +$18.3K 0.24% 48
2024
Q4
$2.59M Buy
3,353
+209
+7% +$173K 0.22% 51
2024
Q3
$2.79M Buy
3,144
+247
+9% +$222K 0.26% 45
2024
Q2
$2.62M Sell
2,897
-20
-0.7% -$16K 0.26% 44
2024
Q1
$2.27M Buy
2,917
+196
+7% +$139K 0.23% 48
2023
Q4
$1.59M Buy
2,721
+155
+6% +$90.5K 0.17% 66
2023
Q3
$1.38M Sell
2,566
-101
-4% -$52K 0.17% 69
2023
Q2
$1.25M Buy
2,667
+61
+2% +$25.6K 0.15% 77
2023
Q1
$895K Buy
2,606
+34
+1% +$11.5K 0.11% 105
2022
Q4
$941K Sell
2,572
-1,572
-38% -$557K 0.12% 91
2022
Q3
$1.34M Buy
4,144
+43
+1% +$13.6K 0.2% 60
2022
Q2
$1.33M Buy
4,101
+343
+9% +$103K 0.2% 63
2022
Q1
$1.08M Sell
3,758
-42
-1% -$10.8K 0.15% 90
2021
Q4
$1.05M Buy
3,800
+11
+0.3% +$2.79K 0.15% 100
2021
Q3
$875K Sell
3,789
-483
-11% -$119K 0.14% 105
2021
Q2
$981K Buy
4,272
+187
+5% +$37.6K 0.16% 98
2021
Q1
$763K Buy
4,085
+802
+24% +$157K 0.13% 120
2020
Q4
$554K Buy
3,283
+143
+5% +$21.4K 0.13% 61
2020
Q3
$465K Sell
3,140
-1,816
-37% -$281K 0.14% 51
2020
Q2
$814K Buy
4,956
+3,405
+220% +$523K 0.25% 41
2020
Q1
$215K Buy
1,551
+10
+0.6% +$1.37K 0.08% 83
2019
Q4
$203K Buy
+1,541
New +$179K 0.08% 98

Other funds holding LLY

Marcum Wealth's LLY Position: Q1 2025 in Review

Marcum Wealth increased its Eli Lilly (LLY) stake by 0.66% in Q1 2025, buying an estimated $18.3K and bringing the position to 3,375 shares worth $2.79M. The position accounts for 0.24% of the portfolio, ranked #48.

Marcum Wealth first reported a position in LLY in Q4 2019 and has held it in 22 quarters since. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Marcum Wealth held 3,375 shares of Eli Lilly worth $2.79M as of Q1 2025.
  • Marcum Wealth bought 22 Eli Lilly shares in Q1 2025, an estimated $18.3K.
  • Eli Lilly made up 0.24% of Marcum Wealth's portfolio in Q1 2025, its #48 holding.
  • Marcum Wealth first reported a position in Eli Lilly in Q4 2019 and has held it in 22 quarters since.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.